Antiarrhythmic and circulatory effects of Astra W36095, a new lidocaine-like agent.
D000813:Anilides / Q000097:blood / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000097:blood / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D001794:Blood Pressure / Q000187:drug effects; D055598:Chemical Phenomena; D002621:Chemistry; D002849:Chromatography, Gas; D003326:Coronary Circulation / Q000187:drug effects*; D003864:Depression, Chemical; D004195:Disease Models, Animal; D004562:Electrocardiography; D005021:Ethylamines / Q000097:blood / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D006207:Half-Life; D006321:Heart / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006352:Heart Ventricles / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D007511:Ischemia; D008012:Lidocaine / Q000627:therapeutic use; D012039:Regional Blood Flow / Q000187:drug effects; D013997:Time Factors
D000813:Anilides; D000889:Anti-Arrhythmia Agents; D005021:Ethylamines; D008012:Lidocaine